Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Amgen Inc.
Current Parent CompanyAmgen
Parent at the Time of the Penalty Announcement subscribe to see this data field
Penalty: $762,000,000
Year: 2012
Date: December 19, 2012
Offense Group: healthcare-related offenses
Primary Offense: off-label or unapproved promotion of medical products
Mega-ScandalPharmaceutical Hazards
Violation Description: U.S. District Judge Sterling Johnson, Jr. accepted a guilty plea by American biotechnology giant Amgen Inc. for illegally introducing a misbranded drug into interstate commerce. The plea is part of a global settlement with the United States in which Amgen agreed to pay $762 million to resolve criminal and civil liability arising from its sale and promotion of certain drugs.
Level of Government: federal
Action Type: agency action
Agency: Food and Drug Administration referral to the Justice Department
Civil or Criminal Case: civil and criminal
HQ Country of Current Parent: USA
HQ State of Current Parent: California
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data(click here)
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.